A Blind Spot in Imaging: Immune Checkpoint Inhibitor-Induced Myocarditis with Negative Cardiac MRI
Immune checkpoint inhibitor (ICI)-induced myocarditis is rare but carries a high morbidity and mortality rate. While cardiac magnetic resonance imaging (CMR) is the first-line imaging modality to support diagnosis, the need for endomyocardial biopsy is needed in negative CMR cases.
Saved in:
| Main Authors: | Lubna Alnatour, Ayham Mahmoud, Ameer Awashra, Jonathan Na, Mohammed Chamsi-Pasha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2025-05-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1597 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis
by: Lorenzo Braghieri, et al.
Published: (2025-04-01) -
Myocarditis in Patients Starting Combination Checkpoint Inhibitor Therapy: Analysis of a Commercial Claims Database
by: Alistair C. Lindsay, et al.
Published: (2025-01-01) -
Diffuse Active Myocarditis in a Teenager with Duchenne Muscular Dystrophy - a case report
by: Mohammad Mahdavi, et al.
Published: (2025-05-01) -
Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01) -
Four challenging cases of eosinophilic endocarditis or myocarditis with literature review
by: Ping Chen, et al.
Published: (2025-05-01)